Paragon 28 to Present at Upcoming Investor Conferences
03 Novembre 2023 - 1:00PM
Business Wire
Paragon 28, Inc. (NYSE: FNA), a leading medical device company
exclusively focused on the foot and ankle orthopedic market, today
announced that Albert DaCosta, Chairman and CEO and Steve Deitsch,
CFO will be presenting in fireside chats at two upcoming investor
conferences. Paragon 28 will participate in the Stephens Annual
Investment Conference on November 15, 2023, and the 35th Annual
Piper Sandler Healthcare Conference on November 28, 2023.
Event: Stephens Annual Investment Conference Date: Wednesday,
November 15, 2023 Time: 5:00pm ET / 3:00pm MT
Event: 35th Annual Piper Sandler Healthcare Conference Date:
Tuesday, November 28, 2023 Time: 4:30pm ET / 2:30pm MT
Live and archived webcasts of the fireside chats will be
available on the “Investors” section of the Company’s website at
ir.paragon28.com.
About Paragon 28, Inc.
Based in Englewood, CO., Paragon 28, is a leading medical device
company exclusively focused on the foot and ankle orthopedic market
and is dedicated to improving patient lives. From the onset,
Paragon 28® has provided innovative orthopedic solutions,
procedural approaches and instrumentation that cover a wide range
of foot and ankle ailments including fracture fixation, forefoot,
ankle, progressive collapsing foot deformity (PCFD) or flatfoot,
Charcot foot and orthobiologics. The company designs products with
both the patient and surgeon in mind, with the goal of improving
outcomes, reducing ailment recurrence and complication rates, and
making the procedures simpler, consistent, and reproducible.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231103861794/en/
Investor Contact Matthew Brinckman Senior Vice President,
Strategy and Investor Relations Phone: (741) 336-0435
mbrinckman@paragon28.com
Paragon 28 (NYSE:FNA)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Paragon 28 (NYSE:FNA)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024